The Bactericidal Fatty Acid Mimetic 2CCA-1 Selectively Targets Pneumococcal Extracellular Polyunsaturated Fatty Acid

Elisabeth Reithuber1, Priyanka Nannapaneni1, Olena Rzhepishevska2

  • 1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Mbio
|December 16, 2020
PubMed

Insights

A novel compound, 2CCA-1, effectively lyses Streptococcus pneumoniae by disrupting fatty acid metabolism. Resistance emerges through mutations in fakB3 or fabT, revealing a link between host fatty acid uptake and bacterial synthesis.

Area of Science:

  • Microbiology
  • Biochemistry
  • Drug Discovery

Background:

  • Streptococcus pneumoniae causes significant global disease burden, necessitating novel therapeutic strategies.
  • Targeting bacterial fatty acid biosynthesis offers a promising avenue for antibiotic development.
  • The nasopharynx serves as the primary reservoir for S. pneumoniae.

Purpose of the Study:

  • To identify narrow-spectrum antibacterial agents targeting S. pneumoniae.
  • To elucidate the mechanism of action and resistance of novel compounds.
  • To explore the interplay between host fatty acid uptake and bacterial fatty acid synthesis.

Main Methods:

  • Screening for small molecules inducing autolysin-mediated lysis of S. pneumoniae.
  • Structure-activity relationship analysis of identified compounds.
  • Investigating resistance mechanisms through genetic mutation analysis (fakB3, fabT).
  • Lipidomic analysis to identify metabolic products of the compound.

Main Results:

  • 2CCA-1, an alkylated dicyclohexyl carboxylic acid, potently induces S. pneumoniae lysis.
  • Resistance to 2CCA-1 is associated with mutations in fakB3 (host fatty acid uptake) and fabT (endogenous fatty acid synthesis regulation).
  • 2CCA-1 is metabolized as a fatty acid via FakB3, incorporated into toxic phospholipid species, leading to bacterial death.
  • A regulatory connection between host polyunsaturated fatty acid metabolism and endogenous fatty acid synthesis in S. pneumoniae was identified.

Conclusions:

  • 2CCA-1 represents a potent bactericidal agent against S. pneumoniae, acting through a novel mechanism involving fatty acid metabolism.
  • Targeting FakB3 offers a potential narrow-spectrum strategy against S. pneumoniae and related Lactobacillales.
  • Understanding the regulation of fatty acid homeostasis is crucial for developing effective antimicrobial therapies.